Literature DB >> 8636439

Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice.

B Naziruddin1, R Shiroki, S Shishido, T Howard, T Mohanakumar.   

Abstract

An in vivo model system to understand the mechanism of xenograft rejection was established using human peripheral blood leukocyte-reconstituted SCID (hu-PBL-SCID) mice. Human xenoreactive natural antibodies (XNA), of IgM and IgG subtypes, capable of binding to pig aortic endothelial cells (PAEC) were detected in the sera of hu-PBL-SCID by ELISA and flowcytometric methods. Western blot analysis of PAEC lysates showed that IgM and IgG XNA from hu-PBL-SCID recognized xenoantigens with similar molecular mass as those recognized by XNA from normal human serum (NHS). This result demonstrated that hu-PBL-SCID contained XNA representing the same repertoire as that of the NHS. XNA from NHS and hu-PBL-SCID were also able to induce intracellular Ca2+ signals in cultured PAEC several fold above the basal level. This result revealed their functional similarity and demonstrated for the first time that XNA in the absence of C can activate PAEC, which may lead to the pathology of xenograft rejection. In vivo, PAEC transplanted under the kidney capsule of hu-PBL-SCID mice showed deposition of human IgM and mouse C. In summary, the present study demonstrates that hu-PBL-SCID can serve as a useful model to characterize innate immunity against xenograft.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636439      PMCID: PMC507180          DOI: 10.1172/JCI118542

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Transplantation of discordant xenografts: a review of progress.

Authors:  J L Platt; G M Vercellotti; A P Dalmasso; A J Matas; R M Bolman; J S Najarian; F H Bach
Journal:  Immunol Today       Date:  1990-12

2.  Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans.

Authors:  U Galili
Journal:  Immunol Today       Date:  1993-10

Review 3.  Xenotransplantation: problems posed by endothelial cell activation.

Authors:  F H Bach; M L Blakely; W J Van der Werf; B Vanhove; K Stuhlmeier; R de Martin; H Winkler
Journal:  Transplant Proc       Date:  1994-04       Impact factor: 1.066

4.  Porcine platelet antigens recognized by human xenoreactive natural antibodies.

Authors:  J L Platt; Z E Holzknecht
Journal:  Transplantation       Date:  1994-02       Impact factor: 4.939

5.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

Authors:  M S Sandrin; H A Vaughan; P L Dabkowski; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody.

Authors:  M P Soares; D Latinne; M Elsen; J Figueroa; F H Bach; H Bazin
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

7.  Pig aortic endothelial cell antigens recognized by human IgM natural antibodies.

Authors:  P J Tuso; D V Cramer; Y D Middleton; M Kearns-Jonker; C Yasunaga; C A Cosenza; W C Davis; G D Wu; L Makowka
Journal:  Transplantation       Date:  1993-09       Impact factor: 4.939

8.  Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes.

Authors:  J Sandhu; B Shpitz; S Gallinger; N Hozumi
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.

Authors:  A Saxon; E Macy; K Denis; M Tary-Lehmann; O Witte; J Braun
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.

Authors:  R Shiroki; N J Poindexter; E S Woodle; M S Hussain; T Mohanakumar; D W Scharp
Journal:  Transplantation       Date:  1994-06-15       Impact factor: 4.939

View more
  1 in total

1.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.